Demeter Biotechnologies, Ltd.

Calculating rank

USPTO Granted Patents = 4

CIPO Patents = 1

Forward Citations = 78

Loading Chart...

2 inventors (with patents filed for the assignee):

Jesse M Jaynes (4 out of 48 patents)

Gordon R Julian (4 out of 7 patents)

Joan Garbarino (3 patents)

4. William Belknap (0 patent)

4 patents: Sort by Forward Citations

1. 5773413 - Method of combating mammalian neoplasias, and lytic peptides therefor (1998-06-30),

2. 5744445 - Method of treating pulmonary disease states with non-naturally occuring (1998-04-28),

3. 5717064 - Methylated lysine-rich lytic peptides and method of making same by (1998-02-10),

4. 5561107 - Method of enhancing wound healing by stimulating fibroblast and (1996-10-01),

Company Overview

Demeter Biotechnologies, Ltd. is a leading biotech company focused on developing innovative solutions for agriculture. Our cutting-edge technologies aim to improve crop yield, reduce environmental impact, and enhance overall agricultural sustainability. With a strong commitment to research and development, Demeter Biotechnologies is dedicated to creating solutions that address the challenges facing the agriculture industry today.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#135 in Durham, NC

#1,297 in North Carolina

#60,704 in US

Durham, NC, United States of America

Demeter Biotechnologies, Ltd.

Forward Citations = 78

2 inventors:

Jesse M Jaynes (4 out of 48 patents)

Gordon R Julian (4 out of 7 patents)

Joan Garbarino (3 patents)

4. William Belknap (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Demeter Biotechnologies, Ltd.. Retrieved from https://idiyas.com/company/demeter-biotechnologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]